Characteristic | Multisystem inflammatory syndrome in adults | Multisystem inflammatory syndrome in children | Kawasaki disease |
---|---|---|---|
Case definition | Hospital admission of a patient aged ≥ 21 yr without evidence of severe respiratory illness and no alternative plausible diagnosis and involvement of 1 or more extrapulmonary organ systems:
| Patient aged < 21 yr with fevers > 38.0°C for ≥ 24 h, or report of subjective fever lasting ≥ 24 h with laboratory evidence of clinically severe illness requiring hospital admission with multisystem (≥ 2) organ involvement:
| Complete Kawasaki disease: Fevers ≥ 5 d AND ≥ 4 principal clinical features
Fevers ≥ 5 d AND 2–3 compatible clinical criteria, or infants with fevers ≥ 7 d without other explanation. |
Supportive investigations and laboratory finding | Elevated CRP, ferritin, D dimer or IL-6 | Elevated CRP, ESR, fibrinogen, procalcitonin, D dimer, ferritin, lactate dehydrogenase or IL-6, elevated neutrophils, reduced lymphocytes and low albumin | CRP ≥ 3.0 mg/dL (or) ESR ≥ 40 mm/hr AND 1) Positive echocardiogram: From AHA criteria,2 echocardiography is considered positive if any of 3 conditions are met:
2) ≥ 3 supportive laboratory findings (anemia for age, platelet count ≥ 450 000 after 7th day of fevers, albumin ≤ 3.0 g/dL, elevated alanine aminotransferase, leukocytes ≥ 15 000/mm3, or urine with ≥ 10 leukocyte/hpf) |
SARS-CoV-2 | Positive for current or previous SARS-CoV-2 infection (nucleic acid, antigen, or antibody) during admission or in the previous 12 wk | Positive for current or recent SARS-CoV-2 infection by RT-PCR, serology or antigen test, or exposure to a suspected or confirmed COVID-19 case within 4 wk before onset of symptoms | NA |
Note: AHA = American Heart Association, CDC = Centers for Disease Control and Prevention, CRP = C-reactive protein, ESR = erythrocyte sedimentation rate, hpf = high power field, IL-6 = interleukin 6, NA = not applicable, RT-PCR = reverse transcription–polymerase chain reaction.
↵* Erythema and edema of the hands and feet in acute phase or periungual desquamation in subacute phase, or both.
↵† Maculopapular, diffuse erythroderma or erythema multiforme-like.
↵‡ Bilateral bulbar conjunctival injection without exudate.
↵§ Erythema and cracking of lips, strawberry tongue, or erythema of oral and pharyngeal mucosa.